Clinical Trial Update: Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for dupilumab in Japanese patients with chronic rhinosinusitis with nasal polyps; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: COMPLETED | Results posted: 2024-01-22